Gender Differences in Schizophrenia: A Comprehensive Review

Event Type

Research Presentation

Location

Dana Science Building, 2nd floor

Start Date

24-4-2026 1:00 PM

End Date

24-4-2026 2:30 PM

Description

This review synthesizes research on gender differences in schizophrenia across age of onset, symptom presentation, course of illness, biological mechanisms, substance use, and social functioning. Evidence suggests that men experience earlier onset, worse premorbid functioning, more severe negative symptoms, and poorer social functioning. Women displayed later and bimodal onset patterns, stronger affective symptoms, and better social functioning, with their less severe course of illness associated with estrogen's neuroprotective effects. These gender differences contribute to distinct clinical trajectories and treatment needs. This paper argues for the development of gender-specific interventions, including estrogen-based pharmacological interventions for women, and targeted behavioral therapies for men focusing on social skills, substance use, and treatment adherence. Integrating gender-specific considerations in treatment is essential for improving long-term outcomes and creating effective care.

Comments

Under the direction of Dr. Caroline Mann.

This document is currently not available here.

Share

COinS
 
Apr 24th, 1:00 PM Apr 24th, 2:30 PM

Gender Differences in Schizophrenia: A Comprehensive Review

Dana Science Building, 2nd floor

This review synthesizes research on gender differences in schizophrenia across age of onset, symptom presentation, course of illness, biological mechanisms, substance use, and social functioning. Evidence suggests that men experience earlier onset, worse premorbid functioning, more severe negative symptoms, and poorer social functioning. Women displayed later and bimodal onset patterns, stronger affective symptoms, and better social functioning, with their less severe course of illness associated with estrogen's neuroprotective effects. These gender differences contribute to distinct clinical trajectories and treatment needs. This paper argues for the development of gender-specific interventions, including estrogen-based pharmacological interventions for women, and targeted behavioral therapies for men focusing on social skills, substance use, and treatment adherence. Integrating gender-specific considerations in treatment is essential for improving long-term outcomes and creating effective care.